SLC27A3 and nonpapillary renal cell carcinoma: To investigate the in vivo impact of SLC27A3 on TKI resistance in ccRCC, 786-O-PR cells infected with SLC27A3 knockdown lentivirus were selected and injected into distinct groups in situ.